John P. Donoghue Honored with Neurotech Business Report's ''Gold Electrode Award'' for Cyberkinetics' Groundbreaking BrainGate™ Brain-Computer Interface; Cyberkinetics' Founder Recognized as Neurotechnology Pioneer

Business Wire, Oct 24, 2005

FOXBOROUGH, Mass. & SAN FRANCISCO -- Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN) (Cyberkinetics) and Neurotech Business Report today announced that John P. Donoghue, Ph.D., Cyberkinetics' Chief Scientific Officer and Professor and Chairman of the Department of Neuroscience at Brown University, was one of five individuals and organizations within the neurotechnology field recognized for their contribution to the growth and development of the neurotechnology industry. Dr. Donoghue was recognized specifically as the "Neurotechnology Researcher of the Year" for his progress in brain-computer interfaces. The "Gold Electrode Award" was presented and Dr. Donoghue's work was cited on Friday, October 21st, at the "Neurotech Leaders Forum 2005" conference held at the Crowne Plaza San Francisco International Airport. Neurotech Business Report focuses on the business of neurotechnolgy, the application of engineering techniques to human neural and information processing systems.

Dr. Donoghue, a founder of Cyberkinetics, was selected for the award based on his work in the field of brain-computer interfaces, including development of the BrainGate(TM) System and the potential, practical benefits that may be derived from his innovative work. Cyberkinetics' BrainGate(TM) System is being designed to give severely paralyzed individuals, as well as individuals with motor impairment from a variety of causes, a long-term, direct brain-computer interface for the purpose of communication and control of a computer, assistive devices, and, ultimately, their own limbs.

"John Donoghue's work stands out for its culmination in a very promising commercial venture and a very encouraging human trial," said James Cavuoto, editor and publisher of Neurotech Business Report. "Our editors were impressed with the rapid progress from university research to commercial product. John Donoghue's work and the BrainGate(TM) System offer tremendous potential for individuals with neurological disorders--and for all of mankind."

"We are developing John's pioneering BrainGate(TM) System brain-computer interface to enable those with severe paralysis and other neurological conditions to live more productively and independently," added Timothy R. Surgenor, President and Chief Executive Officer of Cyberkinetics Neurotechnology Systems, Inc. "We are also developing the BrainGate(TM) System's underlying core technology in our NeuroPort(TM) System to enable improved diagnosis and treatment for a number of neurological conditions, including epilepsy and brain trauma."

In selecting winners of the "Gold Electrode Award," editors of the Neurotech Business Report considered a wide range of new technologies and product directions in the neurotechnology field. Among these, the editors singled out recipients, including John Donoghue, whose efforts were considered to have broken new ground in the fields of research and restorative therapy. Taken together, the advances highlight the tremendous opportunity emerging within the neurotechnology for medicine and investors.

Tim Surgenor, Cyberkinetics' President and Chief Executive Officer, accepted the award for Dr. Donoghue.

About Neurotech Reports and the Neurotech Business Report

Neurotech Reports serves the scientific, medical engineering and financial communities interested in developing the new field of neurotechnology. Neurotech Reports is dedicated to providing business and technology professionals up-to-date and forward-looking information about the field of neurotechnology and future developments that will affect the venture capital, research, and start-up communities.

Neurotech Business Report is the first publication targeting the business of neurotechnology, the application of engineering techniques to human neural and information processing systems. The newsletter covers the ongoing technology transfer from medical devices to commercial products in emerging markets like computer interfaces and training/simulation, as well as technologies including neural prostheses, neural sensing and stimulation and brain-computer interfaces.

For more information, visit http://www.neurotechreports.com.

About the BrainGate(TM) System

The BrainGate(TM) Neural Interface System is a proprietary, investigational brain-computer interface (BCI) that consists of an internal sensor to detect brain cell activity and external processors that convert these brain signals into a computer-mediated output under the person's own control. The sensor is a tiny silicon chip about the size of a baby aspirin with one hundred electrodes, each thinner than a human hair, that can detect the electrical activity of neurons. The sensor is implanted on the surface of the area of the brain responsible for movement, the motor cortex. A small wire connects the sensor to a pedestal that is placed on the skull, extending through the scalp. An external cable connects the pedestal to a cart containing computers, signal processors and monitors that enable the study operators to determine how well study participants can control devices driven by their neural output - that is, by thought alone. The ultimate goal of the BrainGate(TM) System development program is to create a safe, effective and unobtrusive universal operating system that will enable those with motor impairments resulting from a variety of causes to quickly and reliably control a wide range of devices, including computers, assistive technologies and medical devices, simply by using their thoughts.